Not currently recruiting at University of California Health
A Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedestimated completion
- Principal Investigator
- by Sandip Patel, MD (ucsd)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Sandip Patel, MD (ucsd)
Associate Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 43 research publications. Research interests: cancer immunotherapy · phase 1 clinical trials · cellular therapy · immunometabolism · microbiome · IDO · personalized medicine · precision medicine · CAR-T cell · NK cell · proteomics · immunotherapy
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Kahr Medical
- ID
- NCT04440735
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 100 study participants
- Last Updated